Through subgroup analysis, it was found that expression of PUS1 was abnormally elevated in tumor compared to hepatitis or cirrhosis; it was higher in patients with stage III/IV than in patients with stage I/II, and it was also higher in patients with metastatic tumors than in primary tumors. This evidence concerns the gene PUS1 and metastatic neoplasm.